The PAC036222 Polyclonal Antibody is a valuable tool for researchers studying the CD300A protein, a key player in immune regulation. This antibody, produced in rabbits, is highly specific for human samples and is validated for use in Western blot applications. By binding to the CD300A protein, this antibody enables precise detection and analysis in a variety of cell types, making it ideal for studies in immunology and cancer research.CD300A, also known as an immune inhibitory receptor, is essential for maintaining immune balance by regulating inflammation and suppressing allergic responses.
Its role in immune response modulation makes it a promising target for investigating diseases such as cancer, autoimmune disorders, and chronic inflammatory conditions. Understanding the function of CD300A is crucial for the development of therapies that manipulate or enhance immune activity in these disease contexts.Overall, the PAC036222 Polyclonal Antibody provides researchers with a reliable tool for studying CD300A and its impact on immune regulation, offering valuable insights into potential therapeutic strategies for a range of diseases.
